EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetyl-CoA carboxylase inhibition increases retinal pigment epithelial cell fatty acid flux and restricts apolipoprotein efflux

Daniel T Hass, Kriti Pandey, Abbi Engel, Noah Horton, Cameron D Haydinger, Brian M Robbings, Rayne R Lim, Martin Sadilek, Qitao Zhang, Gillian A Gulette, Amy Li, Libin Xu und 3 weitere

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Daniel T Hass und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Washington, Seattle, Washington, USA. Electronic address: dhass@uw.edu. Hauptthemen laut MEDLINE: Retinal Pigment Epithelium, Acetyl-CoA Carboxylase, Fatty Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid-rich deposits called drusen accumulate under the retinal pigment epithelium (RPE) in the eyes of patients with age-related macular degeneration and Sorsby's fundus dystrophy (SFD). Drusen may contribute to photoreceptor degeneration in these blinding diseases. Stimulating β-oxidation of fatty acids could decrease the availability of lipid with which RPE cells generate drusen. Inhibitors of acetyl-CoA carboxylase (ACC) stimulate β-oxidation and diminish lipid accumulation in fatty liver disease. In this report, we test the hypothesis that an ACC inhibitor, Firsocostat, can diminish lipid deposition by RPE cells. We probed metabolism and cellular function in mouse RPE-choroid tissue and human RPE cells. We used 13C6-glucose, 13C16-palmitate, and gas chromatography-linked mass spectrometry to monitor effects of Firsocostat on glycolytic, Krebs cycle, and fatty acid metabolism. We quantified lipid abundance, apolipoprotein E levels, and vascular endothelial growth factor release using liquid chromatography-mass spectrometry, ELISAs, and immunostaining. RPE barrier function was assessed by trans-epithelial electrical resistance (TEER). Firsocostat-mediated ACC inhibition increases β-oxidation, decreases intracellular lipid levels, diminishes lipoprotein release, and increases TEER. When human serum or outer segments are used to stimulate lipoprotein release, fewer lipoproteins are released in the presence of Firsocostat. In a culture model of SFD, Firsocostat stimulates fatty acid oxidation, increases TEER, and decreases apolipoprotein E release. We conclude that Firsocostat remodels RPE metabolism and can limit lipid deposition. This suggests that ACC inhibition could be an effective strategy for diminishing pathologic drusen in the eyes of patients with age-related macular degeneration or SFD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Pigment EpitheliumAcetyl-CoA CarboxylaseFatty AcidsHumansAnimalsMiceEpithelial CellsApolipoproteins EEnzyme InhibitorsMacular Degeneration

Stichwörter der Autor:innen

age-related macular degenerationapolipoprotein E (ApoE)beta-oxidationenergy metabolismfatty acidretinal degenerationretinal pigment epithelium

Substanzen

Acetyl-CoA CarboxylaseFatty AcidsApolipoproteins EEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Biochemistry, University of Washington, Seattle, Washington, USA. Electronic address: dhass@uw.edu.
  • Department of Biochemistry, University of Washington, Seattle, Washington, USA.
  • Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Hospital, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
  • Department of Chemistry, University of Washington, Seattle, Washington, USA.

Förderung

  • NEI NIH HHS
  • NIH HHS
  • NICHD NIH HHS
  • NIBIB NIH HHS
  • National Institutes of Health
  • BrightFocus Foundation
  • National Eye Institute
  • Research to Prevent Blindness

Zitieren

APA

Hass, D. T., Pandey, K., Engel, A., Horton, N., Haydinger, C. D., Robbings, B. M., Lim, R. R., Sadilek, M., Zhang, Q., Gulette, G. A., Li, A., Xu, L., Miller, J. M. L., Chao, J. R., & Hurley, J. B. (2024). Acetyl-CoA carboxylase inhibition increases retinal pigment epithelial cell fatty acid flux and restricts apolipoprotein efflux. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107772

Vancouver

Hass DT, Pandey K, Engel A, Horton N, Haydinger CD, Robbings BM, et al. Acetyl-CoA carboxylase inhibition increases retinal pigment epithelial cell fatty acid flux and restricts apolipoprotein efflux. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107772

BibTeX
@article{Hass2024,
  author = {Hass, Daniel T and Pandey, Kriti and Engel, Abbi and Horton, Noah and Haydinger, Cameron D and Robbings, Brian M and Lim, Rayne R and Sadilek, Martin and Zhang, Qitao and Gulette, Gillian A and Li, Amy and Xu, Libin and Miller, Jason M L and Chao, Jennifer R and Hurley, James B},
  title = {Acetyl-CoA carboxylase inhibition increases retinal pigment epithelial cell fatty acid flux and restricts apolipoprotein efflux},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107772}
}
Kostenlos starten →